4//SEC Filing
DUNAYEVICH EDUARDO 4
Accession 0001181431-09-021164
CIK 0001382911other
Filed
Apr 26, 8:00 PM ET
Accepted
Apr 27, 7:40 PM ET
Size
6.1 KB
Accession
0001181431-09-021164
Insider Transaction Report
Form 4
DUNAYEVICH EDUARDO
Chief Medical Officer
Transactions
- Award
Stock option (right to buy)
2009-04-23+58,112→ 58,112 totalExercise: $2.13Exp: 2019-04-22→ Common Stock (58,112 underlying)
Footnotes (2)
- [F1]1/48th of the total number of shares of stock subject to the option (rounded down to the next whole number of shares) shall vest on the same day of each one-month period of the reporting person's service as an employee, director or consultant following 4/23/2009, so that all of the shares of the stock subject to the option shall be vested on 4/23/2013, subject to the reporting person's continued service relationship (whether as an employee, director or consultant) with the Company or any parent or subsidiary on each such date.
- [F2]Not applicable.
Documents
Issuer
Orexigen Therapeutics, Inc.
CIK 0001382911
Entity typeother
Related Parties
1- filerCIK 0001396783
Filing Metadata
- Form type
- 4
- Filed
- Apr 26, 8:00 PM ET
- Accepted
- Apr 27, 7:40 PM ET
- Size
- 6.1 KB